Wellvone and toxic epidermal necrolysis Patient Reports February 12, 2012

Wellvone Side Effects Report #5585587-8
Wellvone side effect was reported by a Consumer or non-health professional from FRANCE on Dec 31, 2007. Male patient, 24 years of age, was treated with Wellvone. After drug was administered, patient experienced the following side effects: rash , rash erythematous, skin disorder, toxic epidermal necrolysis. Wellvone dosage: unknown. During the same period patient was treated with TRIATEC, TAHOR, KARDEGIC, AMLOR, BRISTOPEN. Patient was hospitalized. Patient recovered.

Wellvone Side Effects Report #5702732-1
Wellvone side effect was reported by a Consumer or non-health professional from FRANCE on Mar 31, 2008. Male patient, 24 years of age, was treated with Wellvone. After drug was administered, patient experienced the following side effects: mucous membrane disorder, pyrexia, rash , rash erythematous, skin disorder, staphylococcal bacteraemia, toxic epidermal necrolysis. Wellvone dosage: unknown. During the same period patient was treated with TRIATEC, ATORVASTATIN CALCIUM, KARDEGIC, AMLOR, BRISTOPEN. Patient was hospitalized. Patient recovered.

Wellvone Side Effects Report #5789038-X
Wellvone side effect was reported by a Consumer or non-health professional from FRANCE on June 19, 2008. Male patient, 24 years of age, was treated with Wellvone. After drug was administered, patient experienced the following side effects: mucous membrane disorder, pyrexia, rash , rash erythematous, skin disorder, staphylococcal bacteraemia, toxic epidermal necrolysis. Wellvone dosage: unknown. During the same period patient was treated with RAMIPRIL, TAHOR, AMLOR, ASPIRIN, BRISTOPEN. Patient was hospitalized. Patient recovered.